Motilal Oswal
In this note, we explored the specialty pipeline of SUNP, examining products under development, the commercialized portfolio, and the competitive dynamics within each segment.
Motilal Oswal released a Buy report for Sun Pharmaceutical Industries Ltd. with a price target of 1960.0 on 23 Sep, 2025.
More from Sun Pharmaceutical Industries Ltd.
Recommended